Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world,
estimated to be responsible for hundreds of thousands of deaths annually. Our …

Implantable cardioverter defibrillator (ICD) programming involves several parameters. In
recent years antitachycardia pacing (ATP) has gained an increasing importance in the …

Background Strong electric shocks are the gold standard for ventricular defibrillation but are
associated with pain and tissue damage. We hypothesized that targeting the excitable gap …

Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …

Impaired left atrial emptying fraction (LAEF) is an important predictor of mortality in patients
with heart failure. As it may reflect increased LV wall stress, it might predict ventricular …

The main eligibility criterion for primary prevention implantable cardioverter defibrillator
(ICD) therapy, that is, left ventricular ejection fraction (LVEF), is based on large clinical trials …

Background The Heart Rhythm Society, the European Heart Rhythm Association, the Asia
Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society expert consensus …

Chagas cardiomyopathy is a parasitic infection caused by Trypanosoma cruzi. Structural
and functional abnormalities are the result of direct myocardial damage by the parasite …

Background Antitachycardia pacing (ATP) is routinely used to terminate ventricular
tachyarrhythmias (VTs). However, little guidance exists on the most effective programming of …

Background An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic
device for preventing sudden cardiac death in patients with sustained ventricular …